<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04074941</url>
  </required_header>
  <id_info>
    <org_study_id>IRB-2019-22</org_study_id>
    <nct_id>NCT04074941</nct_id>
  </id_info>
  <brief_title>The Effect of Sodium Reduction on Blood Pressure and Physical Function in Older Adults</brief_title>
  <acronym>SOTRUE</acronym>
  <official_title>The Effect of Sodium Reduction on Blood Pressure and Physical Function in Older Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hebrew Rehabilitation Center, Boston</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hebrew SeniorLife</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beth Israel Deaconess Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hebrew Rehabilitation Center, Boston</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will examine the effects of low sodium meal plan on seated blood pressure in older
      adults from a community-based, congregate senior living facility.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Hypertension in older adults is a known contributor to both cardiovascular disease and falls.
      The Centers of Disease Control advocates for low sodium, senior meal plans as a strategy to
      lower blood pressure (BP). However, sodium is recommended to treat orthostatic hypotension
      (OH), a risk factor of falls. The long-term effects of low sodium intake on physical function
      are largely unknown in older adults.

      The objective of this proposed pilot study is to determine the feasibility of an
      individual-level, randomized feeding study that examines the impact of sodium reduction on BP
      regulation among 40 semi-independent, older adults aged 60 and above.

      Primary Aim 1: To determine the effects of a low sodium (&lt;0.9 mg per kcal of energy intake),
      2-week meal plan compared with a usual meal plan (average sodium ~2 mg per kcal of energy
      intake) on seated BP among independently living older adults.

      Hypothesis Aim 1: Compared with the usual meal plan, a reduced sodium meal plan will lower
      seated BP in older adults after 2 weeks.

      Feasibility Aim 1: To evaluate the recruitment experience, meal cost, meal delivery
      logistics, and compliance with and tolerability of the meal plan (urine sodium and
      palatability questionnaires).

      Feasibility Aim 2: To determine effect size (variance) of secondary outcomes: standing BP, OH
      (standing minus seated BP), orthostatic symptoms, and a timed up and go test (TUG).

      Eligible participants will be randomized to low versus usual sodium meal plans for two weeks.
      Assessments will be made at the in-person baseline visit, one week telephonic interview and 2
      week in person follow-up visit.

      The primary outcome is seated BP and secondary outcomes include orthostatic hypertension and
      Timed Up and Go (TUG) tests. Both primary and secondary outcomes will be measured twice: (1)
      before the study begins (baseline), and (2) after 2 week period. Patient-reported outcomes,
      dietary compliance, and urine electrolytes will be assessed as well.

      Intent-to-treat analysis will be conducted for all endpoints.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 30, 2019</start_date>
  <completion_date type="Actual">November 4, 2019</completion_date>
  <primary_completion_date type="Actual">November 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Participants will be randomized to either a low sodium diet or a usual sodium diet for a period of two weeks.</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
    <masking_description>Study staff involved in administering the dietary intervention and assessing compliance will be masked to participants' outcome assessments (e.g. BP).</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Seated blood pressure</measure>
    <time_frame>2 weeks</time_frame>
    <description>Average of three seated systolic and diastolic blood pressure readings</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Orthostatic hypotension</measure>
    <time_frame>2 weeks</time_frame>
    <description>Measured from supine and standing systolic and diastolic blood pressure readings</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Timed up and go test</measure>
    <time_frame>2 weeks</time_frame>
    <description>Participant will be asked to start from seated position, stand up from the chair, walk 3 meters in a straight line, turn, walk back to the chair and sit down. The investigators will use average of the two trials.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Hypertension</condition>
  <condition>Physical Disability</condition>
  <condition>Aging</condition>
  <arm_group>
    <arm_group_label>Low sodium diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This group will get a low sodium diet (&lt;0.9 mg per kcal of energy intake).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual sodium diet</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This group will get a usual sodium diet (~2 mg per kcal of energy intake).</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Dietary intervention</intervention_name>
    <description>Intervention include low sodium or usual sodium diet</description>
    <arm_group_label>Low sodium diet</arm_group_label>
    <arm_group_label>Usual sodium diet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Resident at Jack Satter House in Revere

          -  Age &gt;= 60 years

          -  Resting systolic blood pressure 100-149 mm Hg and diastolic blood pressure &lt;100 mm Hg

          -  Stable BP medications (no recent or intended changes)

        Exclusion Criteria:

          -  Cognitive Impairment (Montreal Cognitive Assessment test &lt;18)

          -  Unstable blood pressure medications in the past 2 months

          -  Terminal or mental illness

          -  Severe allergies to common foods

          -  Unwillingness to comply with the diet

          -  Physical inability to do a timed up and go test

          -  Active kidney dialysis or history of kidney transplant
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shivani Sahni, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Marcus Institute, Hebrew SeniorLife and Harvard Medical School</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Jack Satter House</name>
      <address>
        <city>Revere</city>
        <state>Massachusetts</state>
        <zip>02151</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>August 28, 2019</study_first_submitted>
  <study_first_submitted_qc>August 29, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 30, 2019</study_first_posted>
  <last_update_submitted>November 25, 2019</last_update_submitted>
  <last_update_submitted_qc>November 25, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 26, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hebrew Rehabilitation Center, Boston</investigator_affiliation>
    <investigator_full_name>Shivani Sahni</investigator_full_name>
    <investigator_title>Associate Scientist</investigator_title>
  </responsible_party>
  <keyword>Sodium Intake</keyword>
  <keyword>Blood Pressure</keyword>
  <keyword>Hypertension</keyword>
  <keyword>Physical Function</keyword>
  <keyword>Older Adults</keyword>
  <keyword>Randomized Controlled Trial</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>October 29, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/41/NCT04074941/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>September 27, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/41/NCT04074941/ICF_001.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>October 29, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/41/NCT04074941/SAP_002.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

